tiprankstipranks
MaxCyte Director Executes Stock Options and Sells Shares
Company Announcements

MaxCyte Director Executes Stock Options and Sells Shares

MaxCyte (MXCT) has released an update.

Don't Miss our Black Friday Offers:

MaxCyte, Inc. has announced that John Johnston, a Non-Executive Director, exercised options for 3,000 shares of common stock and subsequently sold them at prices ranging from $3.800 to $3.870 per share. This transaction, completed under a prearranged trading plan, represents a minor change in Johnston’s holdings, now owning 120,583 shares and retaining options and restricted stock units. MaxCyte continues to position itself as a leader in cell-engineering platform technologies, aiming to transform human health through its ExPERT™ platform.

For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskMaxCyte Weighs Delisting from AIM to Prioritize Nasdaq: Potential Benefits and Risks Ahead
TipRanks UK Auto-Generated NewsdeskMaxCyte’s Revenue Grows and Strategic Moves Unveiled
TipRanks UK Auto-Generated NewsdeskMaxCyte Files Quarterly Report, Highlights Financial Progress
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App